PL
SNPS icon

Pluribus Labs’s Synopsys SNPS Stock Holding History

Pluribus Labs’s Portfolio SNPS Stock Details SNPS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		$464K Buy
+1,529
New +$461K 0.85% 33

Other funds holding SNPS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
PAMS
Pictet Asset Management (Switzerland) Geneva 73, Switzerland $84.3B AUM 26.5% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Pluribus Labs's SNPS Position: Q2 2022 in Review

Pluribus Labs opened a new position in Synopsys (SNPS) in Q2 2022: 1,529 shares worth $464K. The stake represents 0.85% of the portfolio and ranks #33 among its holdings.

835 funds tracked by Wall St. Rank hold SNPS as of Q2 2022.

  • Pluribus Labs held 1,529 shares of Synopsys worth $464K as of Q2 2022.
  • Synopsys was a new Pluribus Labs position in Q2 2022.
  • Synopsys made up 0.85% of Pluribus Labs's portfolio in Q2 2022, its #33 holding.
  • 835 funds tracked by Wall St. Rank held Synopsys as of Q2 2022.

Based on Pluribus Labs's 13F filing for Q2 2022, filed 12 Aug 2022.